Hepatitis D: advances and challenges

Zhijiang Miao1, Zhenrong Xie2, Li Ren3

  • 1Postgraduate School Molecular Medicine, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.

Insights

Hepatitis D virus (HDV) causes severe hepatitis, leading to rapid cirrhosis and cancer. This review details recent advances in HDV research, treatment, and prevention, highlighting challenges and opportunities for future progress.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis D virus (HDV) infection is associated with severe liver disease progression.
  • Despite its severity, HDV has received limited scientific and public attention for over 40 years.
  • Combating HDV necessitates enhanced scientific understanding and multi-stakeholder collaboration.

Purpose of the Study:

  • To review recent advancements in Hepatitis D virus (HDV) virology, epidemiology, clinical manifestations, and treatment strategies.
  • To identify current challenges and future opportunities in the field of HDV research and management.

Main Methods:

  • Comprehensive literature review of recent studies on HDV.
  • Analysis of epidemiological data, clinical features, and therapeutic interventions.
  • Synthesis of findings to highlight progress and remaining gaps.

Main Results:

  • Recent advances have been made in understanding HDV virology and epidemiology.
  • New treatment options are emerging, offering improved clinical outcomes.
  • Significant challenges remain in prevention and widespread treatment access.

Conclusions:

  • Effective control of Hepatitis D requires continued scientific investigation and collaborative efforts.
  • Further research is crucial to address remaining challenges in HDV treatment and prevention.
  • The field is poised for progress with emerging opportunities in HDV management.